array:19 [
  "pii" => "X0211699500025658"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2000-02-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2000;20 Supl 1:40"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1444
    "formatos" => array:3 [
      "EPUB" => 148
      "HTML" => 1013
      "PDF" => 283
    ]
  ]
  "itemSiguiente" => array:15 [
    "pii" => "X021169950002564X"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:41-2"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1801
      "formatos" => array:3 [
        "EPUB" => 152
        "HTML" => 1353
        "PDF" => 296
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Hipertensión arterial prediálisis: Factor pronóstico de morbi-mortalidad durante el tratamiento sustitutivo"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "41"
          "paginaFinal" => "42"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "M. FERNÁNDEZ LUCAS , J. L. TERUEL , J. ORTUÑO"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "M. FERNÁNDEZ LUCAS , J. L. TERUEL , J. ORTUÑO"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X021169950002564X?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X021169950002564X/v0_201502091333/es/main.assets"
  ]
  "itemAnterior" => array:15 [
    "pii" => "X0211699500025666"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:38-9"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1866
      "formatos" => array:3 [
        "EPUB" => 149
        "HTML" => 1398
        "PDF" => 319
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "HTA en niños y adolescentes"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "38"
          "paginaFinal" => "39"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "A. LUQUE"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "A. LUQUE"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025666?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025666/v0_201502091333/es/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "«HIPERTENSIÓN Y ENFERMEDAD CARDIOVASCULAR EN HEMODIÁLISIS» The effect of dialysis dosage on morbidity and mortality of hemodialysis patients"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "40"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "J. C. AYUS , D. SHEIKH-HAMAD"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "J. C. AYUS , D. SHEIKH-HAMAD"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Vol. XX. Suplemento 1. 2000 «HIPERTENSIÓN Y ENFERMEDAD CARDIOVASCULAR EN HEMODIÁLISIS» The effect of dialysis dosage on morbidity and mortality of hemodialysis patients J. C. Ayus and D. Sheikh-Hamad From the Renal Division, Baylor College of Medicine, Houston, Texas. Mortality rate of American hemodialysis patients is among the highest of the industrialized nations, and it was suggested that it may be related to decreased dialysis dosage. In this study we sought to evaluate the effect of increasing dialysis dosage on the morbidity and mortality of chronic hemodialysis patients. The morbidity and mortality of 78 hemodialysis patients were studied prospectively over a 12 months period after intensifying the dialysis prescription, and was compared to that of the preceding 12 months. The mean age of the patient population was 56 years and the mean length of time on dialysis was 5.86 years&#59; 46 were females and 32 were males&#59; 40% of all patients were diabetic. Prescribed dialysis dosage: A minimum of 4 hours three times a week (22% were dialyzed more than 4 hours)&#59; blood flow of 500 ml/min&#59; dialysate flow of 800 ml/min. Previous dialysis dosage: consisted of 4 hours of dialysis three times a week&#59; blood flow of 300-350 ml/min&#59; dialysate flow of 500 ml/min. All patients were dialyzed using polysurfone membrane without dialyzer reuse. Results: prior to the study pe- riod, the mean Urea Reduction Rate (URR) was 71.6%, with 29% of the patients having URR < 65%. The mean URR during the study period increased to 75.7%, with less than 5.8% of the patients having URR < 65% (p < 0.05). While the mean albumin concentration was the same during both periods (3.8 g/dl), the fraction of patients having Alb < 3.5 g/dl, decreased from 16 to 8%. Likewise, the mean Hematocrit (Hct) did not change (33.4% prior to increasing dialysis prescription, vs 33.7% after), but the fraction of patients having Hct < 28% decreased from 13 to 3%, in the face of declining EPO requirement. In addition, concomitant with an average reduction of 2.2 kg in mean dry weight, there was a significant reduction in the number of patients requiring blood pressure medications from 70 to 20%. Gross mortality decreased from 12 to 7% (p < 0.05), and the fraction of hospitalized patients at any given month decreased from 3% to < 2%. Conclusion: During a single year observation, we find that increased dialysis dosage significantly reduces morbidity and mortality on hemodialysis. 40 "
    "pdfFichero" => "P7-E170-S140-A1889.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025658/v0_201502091333/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35407"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Suplementos"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/00000020000000S1/v0_201502091333/X0211699500025658/v0_201502091333/en/P7-E170-S140-A1889.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025658?idApp=UINPBA000064"
]
Compartir
Información de la revista

Estadísticas

Siga este enlace para acceder al texto completo del artículo

«HIPERTENSIÓN Y ENFERMEDAD CARDIOVASCULAR EN HEMODIÁLISIS» The effect of dialysis dosage on morbidity and mortality of hemodialysis patients
J. C. AYUS , D. SHEIKH-HAMAD
Leído
4062
Veces
se ha leído el artículo
1522
Total PDF
2540
Total HTML
Compartir estadísticas
 array:19 [
  "pii" => "X0211699500025658"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2000-02-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2000;20 Supl 1:40"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1444
    "formatos" => array:3 [
      "EPUB" => 148
      "HTML" => 1013
      "PDF" => 283
    ]
  ]
  "itemSiguiente" => array:15 [
    "pii" => "X021169950002564X"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:41-2"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1801
      "formatos" => array:3 [
        "EPUB" => 152
        "HTML" => 1353
        "PDF" => 296
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Hipertensión arterial prediálisis: Factor pronóstico de morbi-mortalidad durante el tratamiento sustitutivo"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "41"
          "paginaFinal" => "42"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "M. FERNÁNDEZ LUCAS , J. L. TERUEL , J. ORTUÑO"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "M. FERNÁNDEZ LUCAS , J. L. TERUEL , J. ORTUÑO"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X021169950002564X?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X021169950002564X/v0_201502091333/es/main.assets"
  ]
  "itemAnterior" => array:15 [
    "pii" => "X0211699500025666"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:38-9"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1866
      "formatos" => array:3 [
        "EPUB" => 149
        "HTML" => 1398
        "PDF" => 319
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "HTA en niños y adolescentes"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "38"
          "paginaFinal" => "39"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "A. LUQUE"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "A. LUQUE"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025666?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025666/v0_201502091333/es/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "«HIPERTENSIÓN Y ENFERMEDAD CARDIOVASCULAR EN HEMODIÁLISIS» The effect of dialysis dosage on morbidity and mortality of hemodialysis patients"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "40"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "J. C. AYUS , D. SHEIKH-HAMAD"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "J. C. AYUS , D. SHEIKH-HAMAD"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Vol. XX. Suplemento 1. 2000 «HIPERTENSIÓN Y ENFERMEDAD CARDIOVASCULAR EN HEMODIÁLISIS» The effect of dialysis dosage on morbidity and mortality of hemodialysis patients J. C. Ayus and D. Sheikh-Hamad From the Renal Division, Baylor College of Medicine, Houston, Texas. Mortality rate of American hemodialysis patients is among the highest of the industrialized nations, and it was suggested that it may be related to decreased dialysis dosage. In this study we sought to evaluate the effect of increasing dialysis dosage on the morbidity and mortality of chronic hemodialysis patients. The morbidity and mortality of 78 hemodialysis patients were studied prospectively over a 12 months period after intensifying the dialysis prescription, and was compared to that of the preceding 12 months. The mean age of the patient population was 56 years and the mean length of time on dialysis was 5.86 years&#59; 46 were females and 32 were males&#59; 40% of all patients were diabetic. Prescribed dialysis dosage: A minimum of 4 hours three times a week (22% were dialyzed more than 4 hours)&#59; blood flow of 500 ml/min&#59; dialysate flow of 800 ml/min. Previous dialysis dosage: consisted of 4 hours of dialysis three times a week&#59; blood flow of 300-350 ml/min&#59; dialysate flow of 500 ml/min. All patients were dialyzed using polysurfone membrane without dialyzer reuse. Results: prior to the study pe- riod, the mean Urea Reduction Rate (URR) was 71.6%, with 29% of the patients having URR < 65%. The mean URR during the study period increased to 75.7%, with less than 5.8% of the patients having URR < 65% (p < 0.05). While the mean albumin concentration was the same during both periods (3.8 g/dl), the fraction of patients having Alb < 3.5 g/dl, decreased from 16 to 8%. Likewise, the mean Hematocrit (Hct) did not change (33.4% prior to increasing dialysis prescription, vs 33.7% after), but the fraction of patients having Hct < 28% decreased from 13 to 3%, in the face of declining EPO requirement. In addition, concomitant with an average reduction of 2.2 kg in mean dry weight, there was a significant reduction in the number of patients requiring blood pressure medications from 70 to 20%. Gross mortality decreased from 12 to 7% (p < 0.05), and the fraction of hospitalized patients at any given month decreased from 3% to < 2%. Conclusion: During a single year observation, we find that increased dialysis dosage significantly reduces morbidity and mortality on hemodialysis. 40 "
    "pdfFichero" => "P7-E170-S140-A1889.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025658/v0_201502091333/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35407"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Suplementos"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/00000020000000S1/v0_201502091333/X0211699500025658/v0_201502091333/en/P7-E170-S140-A1889.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025658?idApp=UINPBA000064"
]
Información del artículo
ISSN: 02116995
Idioma original: Inglés
Datos actualizados diariamente
año/Mes Html Pdf Total
2024 Noviembre 6 6 12
2024 Octubre 25 33 58
2024 Septiembre 35 20 55
2024 Agosto 51 49 100
2024 Julio 38 32 70
2024 Junio 38 21 59
2024 Mayo 54 37 91
2024 Abril 47 16 63
2024 Marzo 58 20 78
2024 Febrero 38 35 73
2024 Enero 21 23 44
2023 Diciembre 24 20 44
2023 Noviembre 26 31 57
2023 Octubre 26 28 54
2023 Septiembre 26 22 48
2023 Agosto 24 24 48
2023 Julio 43 30 73
2023 Junio 73 17 90
2023 Mayo 57 30 87
2023 Abril 49 14 63
2023 Marzo 59 23 82
2023 Febrero 44 13 57
2023 Enero 26 19 45
2022 Diciembre 23 26 49
2022 Noviembre 24 25 49
2022 Octubre 29 28 57
2022 Septiembre 19 19 38
2022 Agosto 26 29 55
2022 Julio 25 38 63
2022 Junio 20 20 40
2022 Mayo 15 18 33
2022 Abril 28 28 56
2022 Marzo 20 44 64
2022 Febrero 24 28 52
2022 Enero 26 22 48
2021 Diciembre 19 35 54
2021 Noviembre 22 24 46
2021 Octubre 23 32 55
2021 Septiembre 16 27 43
2021 Agosto 20 27 47
2021 Julio 14 26 40
2021 Junio 12 12 24
2021 Mayo 15 18 33
2021 Abril 24 32 56
2021 Marzo 32 13 45
2021 Febrero 9 5 14
2021 Enero 6 7 13
2020 Diciembre 12 11 23
2020 Noviembre 6 4 10
2020 Octubre 15 6 21
2020 Septiembre 9 0 9
2020 Agosto 15 7 22
2020 Julio 12 9 21
2020 Junio 16 13 29
2020 Mayo 11 11 22
2020 Abril 24 15 39
2020 Marzo 10 9 19
2020 Febrero 29 16 45
2020 Enero 27 14 41
2019 Diciembre 10 6 16
2019 Noviembre 6 9 15
2019 Octubre 3 2 5
2019 Septiembre 9 12 21
2019 Agosto 2 12 14
2019 Julio 10 10 20
2019 Junio 4 5 9
2019 Mayo 9 7 16
2019 Abril 17 21 38
2019 Marzo 14 9 23
2019 Febrero 4 10 14
2019 Enero 9 5 14
2018 Diciembre 18 15 33
2018 Noviembre 16 8 24
2018 Octubre 19 7 26
2018 Septiembre 17 6 23
2018 Agosto 16 6 22
2018 Julio 18 5 23
2018 Junio 12 7 19
2018 Mayo 13 8 21
2018 Abril 20 3 23
2018 Marzo 9 4 13
2018 Febrero 18 3 21
2018 Enero 5 4 9
2017 Diciembre 13 3 16
2017 Noviembre 10 6 16
2017 Octubre 12 3 15
2017 Septiembre 7 2 9
2017 Agosto 14 8 22
2017 Julio 6 2 8
2017 Junio 12 3 15
2017 Mayo 5 2 7
2017 Abril 6 1 7
2017 Marzo 8 27 35
2017 Febrero 2 1 3
2017 Enero 3 0 3
2016 Diciembre 6 5 11
2016 Noviembre 12 1 13
2016 Octubre 23 9 32
2016 Septiembre 24 1 25
2016 Agosto 42 1 43
2016 Julio 71 2 73
2016 Junio 53 0 53
2016 Mayo 54 0 54
2016 Abril 20 0 20
2016 Marzo 31 0 31
2016 Febrero 38 0 38
2016 Enero 21 0 21
2015 Diciembre 49 0 49
2015 Noviembre 28 0 28
2015 Octubre 31 0 31
2015 Septiembre 36 0 36
2015 Agosto 21 0 21
2015 Julio 16 0 16
2015 Junio 10 0 10
2015 Mayo 13 0 13
Mostrar todo

Siga este enlace para acceder al texto completo del artículo

Idiomas
Nefrología
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?